2018-12-19 |
NeuroVive Pharmaceutical AB |
Magnus Hansson |
Chief Medical Officer |
|
Förvärv |
NeuroVive Pharmaceutical AB |
Aktie |
SE0002575340 |
2018-12-19 |
20 000 |
Antal |
1,31 |
SEK |
|
Anmälan
|
2018-05-06 |
NeuroVive Pharmaceutical AB |
David Olof Rikard Bejker |
Styrelseledamot/suppleant |
|
Teckning |
NeuroVive Pharmaceutical BTU |
|
SE0011089002 |
2018-04-27 |
3 819 |
Antal |
8,00 |
SEK |
|
Anmälan
|
2018-04-25 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Teckning |
NeuroVive Pharmaceutical AB BTU |
|
SE0008241871 |
2018-04-25 |
8 812 |
Antal |
8,00 |
SEK |
Historik |
Anmälan
|
2018-04-25 |
NeuroVive Pharmaceutical AB |
Erik Kinnman |
VD |
|
Förvärv |
NeuroVive Pharmaceutical AB BTU |
|
SE0008241871 |
2018-04-25 |
8 812 |
Antal |
8,00 |
SEK |
Reviderad |
Anmälan
|
2018-04-25 |
NeuroVive Pharmaceutical AB |
Marcus Keep, Eskil Elmée and Michael Vickers |
Board Member, CSO and Chair Nomination in NeuroVive |
Ja |
Avyttring |
Rights Issue Warrants |
|
|
2018-04-20 |
11 623 296 |
Antal |
0,01 |
SEK |
Historik |
Anmälan
|
2018-04-25 |
NeuroVive Pharmaceutical AB |
Marcus Keep, Eskil Elmée and Michael Vickers |
Board Member, CSO and Chair Nomination in NeuroVive |
Ja |
Avyttring |
Rights Issue Warrants |
|
|
2018-04-20 |
11 623 296 |
Antal |
0,11 |
SEK |
Reviderad |
Anmälan
|
2018-04-25 |
NeuroVive Pharmaceutical AB |
Eskil Elmér |
Forskningschef |
|
Teckning |
NeuroVive Pharmaceutical BTU |
|
SE0011089002 |
2018-04-24 |
19 407 |
Antal |
8,00 |
SEK |
|
Anmälan
|
2018-04-25 |
NeuroVive Pharmaceutical AB |
Magnus Hansson |
Chief Medical Officer |
|
Tilldelning |
NeuroVive Pharmaceutical AB BTU |
|
SE0011089002 |
2018-04-24 |
20 000 |
Antal |
8,00 |
SEK |
|
Anmälan
|
2018-04-25 |
NeuroVive Pharmaceutical AB |
Eskil Elmér |
Forskningschef |
|
Avyttring |
NeuroVive Pharmaceutical UR |
|
SE0011088996 |
2018-04-20 |
1 060 905 |
Antal |
0,01 |
SEK |
|
Anmälan
|
2017-02-23 |
NeuroVive Pharmaceutical AB |
ERIK KINNMAN |
VD |
|
Förvärv |
NeuroVive Pharmaceutical AB |
|
SE0002575340 |
2017-02-23 |
8 600 |
Antal |
5,62 |
SEK |
|
Anmälan
|